Avecho Biotechnology Limited (OEZ) — Financial Flexibility Index
Avecho Biotechnology Limited (OEZ) has a Financial Flexibility Index of -0.88x as of December 2022. Free cash flow of €-806.30K (operating CF €-808.80K minus capex €2.50K) represents -1% of total liabilities (€920.66K). Check how strategically is Avecho Biotechnology Limited's equity deployed to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Avecho Biotechnology Limited Financial Flexibility Index (2013–2022)
Historical Financial Flexibility Index trend for Avecho Biotechnology Limited across 10 annual periods. See OEZ working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Avecho Biotechnology Limited (2013–2022)
Year-by-year free cash flow to debt coverage for Avecho Biotechnology Limited. For the full company profile including market capitalisation, see Avecho Biotechnology Limited market capitalisation.
| Year | Flexibility Index | Free Cash Flow (EUR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2022 | -1.75x | €-1.61 Million | €-1.67 Million | €920.66K | ▲ +57.1% |
| 2021 | -4.08x | €-2.90 Million | €-3.10 Million | €709.36K | ▼ -101.5% |
| 2020 | -2.03x | €-1.42 Million | €-1.42 Million | €700.17K | ▼ -195.3% |
| 2019 | 2.13x | €1.18 Million | €1.18 Million | €556.12K | ▲ +187.7% |
| 2018 | -2.42x | €-2.19 Million | €-2.19 Million | €902.04K | ▲ +30.1% |
| 2017 | -3.47x | €-6.37 Million | €-6.42 Million | €1.84 Million | ▲ +6.8% |
| 2016 | -3.72x | €-6.35 Million | €-6.41 Million | €1.71 Million | ▲ +21.6% |
| 2015 | -4.74x | €-8.62 Million | €-8.71 Million | €1.82 Million | ▼ -33.8% |
| 2014 | -3.55x | €-6.64 Million | €-6.74 Million | €1.87 Million | ▲ +8.1% |
| 2013 | -3.86x | €-8.45 Million | €-8.58 Million | €2.19 Million | — |